GlassScriptPhysician profile
Jonathan M Davidorf
NPI 1023105160
$11,802.55
in general payments reported to CMS, 2019-2025
29 companies · $2,827 in 2025
The $2,827 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,439 · 2020: $284 · 2021: $545 · 2022: $1,545 · 2023: $1,731 · 2024: $3,432 · 2025: $2,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,695 · Consulting Fee: $3,250 · Honoraria: $25.59 · Entertainment: $18.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,695.48 |
| Consulting Fee | $3,250.00 |
| Honoraria | $25.59 |
| Entertainment | $18.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $7,412.58 | 2019-2025 | Acrysof Iq Vivity, Acrysof Iq Panoptix Uv Iol, Ngenuity |
| Rxsight INC | $772.81 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Bausch & Lomb Americas INC. | $527.81 | 2022-2025 | Miebo, Xiidra, Victus |
| Abbvie INC. | $411.32 | 2022-2025 | Vuity, Lumigan, Alphagan P |
| Allergan, INC. | $358.21 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $309.05 | 2019-2025 | Cequa, Xelpros |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $287.32 | 2022-2025 | Xifaxan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $257.31 | 2019 | |
| Sight Sciences, INC. | $253.09 | 2019-2022 | |
| Glaukos Corporation | $206.76 | 2025 | Idosetr |
| Carl Zeiss Meditec, INC. | $141.11 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $111.22 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $107.27 | 2025 | Xdemvy |
| Dompe US, INC. | $101.71 | 2022-2024 | Oxervate |
| New World Medical,INC. | $89.12 | 2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $87.95 | 2021 | |
| Biotissue Holdings INC. | $62.03 | 2023-2024 | |
| Oyster Point Pharma, INC. | $56.29 | 2023-2025 | Tyrvaya, Ryzumvi |
| Shire North American Group INC | $46.71 | 2019 | |
| Eyevance Pharmaceuticals LLC | $43.55 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $33.38 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $23.51 | 2021 | |
| Horizon Therapeutics Plc | $21.99 | 2022 | |
| Amgen INC. | $21.92 | 2025 | Tepezza |
| Thea Pharma INC. | $21.01 | 2023 | Iyuzeh |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Optos, INC. | $18.12 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Davidorf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.